Company Analysis

Scilex Holding Company (SCLX)

Nasdaq: SCLX · Biological Products, (No Diagnostic Substances) · Palo Alto, CA · filing with the SEC since 2020
Grade4.1
◀ Past 4.5● Present 3.4▶ Future 4.8
1 est.

The grade of Scilex Holding Company

Nine metrics read from its own filings, by tense
Headline grade
4.1/10
◀ Past4.530% of the headline
● Present3.440% of the headline
▶ Future4.830% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

4.5/1030% of the headline grade · 3 of 3 filed

Surviving crises

as filed
0.2/10

Has it survived what it has been through?

13 warning events since 2020; the latest 2026-05-15.

weight 33% of this tense · 2nd percentile among 159 sector filers · read for itself

From the record

Scilex Holding Company's filings since 2020 show 13 warning events of 4 kinds: a notice about its exchange listing (8-K item 3.01, 3 times, the latest 2024-11-22); a warning not to rely on past financial statements (8-K item 4.02, the latest 2021-12-07); an auditor change (8-K item 4.01, 4 times, the latest 2024-12-06); a late-report notice (Form NT 10-K or NT 10-Q, 5 times, the latest 2026-05-15) (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed
5.2/10

What has it actually done, year after year?

+5.1% a year over 6 filed years; profitable in 0 of 5.

weight 45% of this tense · 52nd percentile among 102 sector filers · read for its customers

From the record

Scilex Holding Company's 6 filed years say what it did: revenue went from $24 million in fiscal 2020 to $30 million in fiscal 2025, up 5.1% a year; it rose in 4 of 5 years; the deepest fall was 47% from fiscal 2024 to fiscal 2025; net income was positive in 0 of 5 of those years (its annual reports).

What it rests on

  • revenue growth over the filed span5.1%bottom 34% of its family
  • the share of years revenue rosetop 24% of its family
  • the share of filed years with a profitbottom 31% of its family
  • the deepest fall from a revenue peak46.5%top 34% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

as filed
9.6/10

How has it treated the people who own it?

Share count shrank 46.3% a year. 100% of cash flow returned. Insiders: 0 sales, 0 purchases.

weight 22% of this tense · 96th percentile among 21 sector filers · read for its shareholders

From the record

Over the 4 fiscal years to 2025-12-31, Scilex Holding Company's diluted share count shrank about 46.3% a year, and dividends and buybacks returned about 100% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 0 sales and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).

What it rests on

  • the share count over the yearstop 1% of its family
  • cash returned against operating cash flowtop 7% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

● Present

What are they doing right now?

3.4/1040% of the headline grade · 3 of 3 filed

Financial health

as filed
4.1/10

Is it financially healthy right now?

Leverage 158%: owes 158¢ per asset dollar.

weight 45% of this tense · 41st percentile among 147 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, Scilex Holding Company's shareholders' equity was below zero, so the profit on it is not read, and gross profitability: its products earned about 34 cents per dollar of everything the company owns. Leverage: it owed about 158 cents per dollar of assets (the filed statements).

What it rests on

  • what it owes per dollar of assetsbottom 11% of its family
  • gross profit against assetstop 29% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed
3.9/10

How strong is its position in its industry?

bottom 39% of 102 in its family.

weight 33% of this tense · 39th percentile among 102 sector filers · read for its customers

From the record

Scilex Holding Company's standing among 102 graded names in its industry family: revenue of $30 million in fiscal 2025 ranks in the bottom 49% by size; revenue growth of -7.3% a year over the last 3 filed years ranks in the bottom 30% (its annual reports).

What it rests on

  • revenue against the family$30.3Mbottom 49% of its family
  • three-year revenue growth-7.3%bottom 30% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

as filed
1.0/10

What are the people in charge doing?

bottom 10% of 110 in its family for leadership; chief executive since 2025.

weight 22% of this tense · 10th percentile among 110 sector filers · read for its shareholders

From the record

Scilex Holding Company's leadership, from its insiders' filings and its current reports: the chief executive on the record is Ji, Henry (Exec Chair, CEO and President, as filed), filing under that title since 2025-10-09, 1.1 years (bottom 15% of its family); the 5 officers and directors filing in the last fifteen months have been on the record a median of 3.1 years (bottom 13%); 7 officer or director changes were reported on Form 8-K since 2023-11-13, against the 5 people in charge now (bottom 3%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

What it rests on

  • officer and director changes on Form 8-K, against the people in charge7 in three years among 5 peoplebottom 3% of its family
  • the median years the people in charge have filed3.1 yearsbottom 13% of its family
  • the chief executive's years on the record1.1 yearsbottom 15% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

▶ Future

What are they set up to do next?

4.8/1030% of the headline grade · 2 of 3 filed, 1 estimated

Room to expand

as filed
5.6/10

How much room does it have to grow?

top 44% of 92 in its family for room to expand.

weight 45% of this tense · 56th percentile among 92 sector filers · read for itself

From the record

Scilex Holding Company's room to grow, from the newest filed statements (fiscal 2025): cash of $5 million against no long-term debt tagged leaves 1.4% of its assets as net cash, bottom 8% of its family; cash from operations less capital spending is 12.2% of revenue (top 15%); a gross margin of 415.8% (top 1%); research spending of 68.5% of revenue (bottom 31%) (its annual report).

What it rests on

  • cash less debt against assets1.4%bottom 8% of its family
  • cash from operations less capital spending against revenue12.2%top 15% of its family
  • gross margin415.8%top 1% of its family
  • research spending against revenue68.5%bottom 31% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed
6.1/10

What could actually drive growth from here?

top 39% of 100 in its family for growth drivers.

weight 33% of this tense · 61st percentile among 100 sector filers · read for its customers

From the record

Scilex Holding Company's growth drivers, from the filed years to fiscal 2025: revenue grew -7.3% a year over the last three filed years against 5.1% over all 6, slowing (bottom 42% of its family); the newest year grew -46.6% (bottom 13%); research spending grew 31.8% a year (top 7%); capital spending grew 166.8% a year (top 3%) (its annual reports). Scilex Holding Company tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

What it rests on

  • three-year growth against the whole span-12.5 points a yearbottom 42% of its family
  • the newest year's revenue growth-46.6%bottom 13% of its family
  • three-year growth of research spending31.8%top 7% of its family
  • three-year growth of capital spending166.8%top 3% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

SI estimate
1.2/10

Did its newest year beat what its own record pointed to?

SI estimate 1.2/10, confidence 35 of 100 (one part).

weight 22% of this tense · 12th percentile among 90 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
Read from one part only, revenue against the prior three years' pace, which ranks in the bottom 12% of 90 in its family; the record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change.
What the record cannot read
The record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change.
How it was reasoned
one part: revenue against the prior three years' pace, the one part on file, ranked among 90 in its family.
Confidence
35 of 100
What would change it
A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Scilex Holding Company's expectations vs reality is put at 1.2 of 10 with a confidence of 35 of 100, because read from one part only, revenue against the prior three years' pace, which ranks in the bottom 12% of 90 in its family; the record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change. A filing that carries the missing parts replaces this estimate with the filed reading.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton SCLX · research, not advice